A Health Technology Assessment of a Proposed Biosimilar for the Treatment of Chemotherapy Induced Febrile Neutropenia- A United States Payer Perspective

May 1, 2014, 00:00
10.1016/j.jval.2014.03.512
https://www.valueinhealthjournal.com/article/S1098-3015(14)00563-4/fulltext
Title : A Health Technology Assessment of a Proposed Biosimilar for the Treatment of Chemotherapy Induced Febrile Neutropenia- A United States Payer Perspective
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00563-4&doi=10.1016/j.jval.2014.03.512
First page : A88
Section Title : Cancer
Open access? : No
Section Order : 1563
Categories :
Tags :
Regions :
ViH Article Tags :